AI assistant
CervoMed Inc. — Director's Dealing 2024
Jun 14, 2024
34364_dirs_2024-06-14_d7bf58c1-6258-4df6-9d49-a6bc542f099a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CervoMed Inc. (CRVO)
CIK: 0001053691
Period of Report: 2024-06-14
Reporting Person: ZAVRL FRANK (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-14 | Stock Option (Right to Buy) | $19.01 | A | 5750 | Acquired | 2034-06-14 | Common Stock (5750) | Direct |
Footnotes
F1: On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date.